L. Vanseymortier
Papers
2
Total Citations
16
H-Index
2
About
L. Vanseymortier is a surgical oncologist whose research focuses on optimizing treatment for rectal cancer, particularly through minimally invasive techniques and organ-preserving strategies. Their most significant contribution is the GRECCAR 2 randomized phase 3 trial, which compared local excision versus total mesorectal excision in patients with T2-T3 low rectal cancer who showed a good response after neoadjuvant radiochemotherapy. This landmark study, published in 2014 and cited 14 times, provided critical preliminary evidence that select patients might safely avoid radical surgery, helping to shape the shift toward less aggressive, function-sparing approaches in rectal cancer management. Vanseymortier has also been an early contributor to the field of robotic surgery for rectal cancer, authoring a 2009 review of initial robotic experiences and reporting their own preliminary outcomes. This work helped introduce and evaluate the feasibility of robotic platforms in a challenging surgical domain. While their publication record is focused, it addresses a pivotal clinical question—balancing oncologic safety with quality of life—and has influenced subsequent trials and guidelines in colorectal surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2Actualité sur la chirurgie robotique du cancer du rectum2 citations · 2009